{"id":"https://openalex.org/W2185220959","doi":null,"title":"EFFECT OF CYP2C9 AND VKORC1 GENETIC POLYMORPHISMS ON WARFARIN DOSE REQUIREMENT IN SOUTH INDIAN POPULATION","display_name":"EFFECT OF CYP2C9 AND VKORC1 GENETIC POLYMORPHISMS ON WARFARIN DOSE REQUIREMENT IN SOUTH INDIAN POPULATION","publication_year":2013,"publication_date":"2013-07-01","ids":{"openalex":"https://openalex.org/W2185220959","mag":"2185220959"},"language":"en","primary_location":{"id":"mag:2185220959","doi":null,"is_oa":false,"landing_page_url":"https://www.ijpp.com/IJPP%20archives/2013_57_3_July%20-%20Sep/308-317.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011334655","display_name":"Sivalingam Madhan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sivalingam Madhan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101868096","display_name":"Dhakchinamoorthi Krishna Kumar","orcid":"https://orcid.org/0000-0001-8591-1636","observed_orcids":["https://orcid.org/0000-0001-8591-1636"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dhakchinamoorthi Krishna Kumar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8591-1636","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091430858","display_name":"Dutta Tarun Kumar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dutta Tarun Kumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026363959","display_name":"Jayaramanm Balachander","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jayaramanm Balachander","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108062327","display_name":"Adithan Chandrasekaran","orcid":"https://orcid.org/0000-0002-0109-6441","observed_orcids":["https://orcid.org/0000-0002-0109-6441"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adithan Chandrasekaran","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0109-6441","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2171,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.49084773,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13984","display_name":"Nutrition, Genetics, and Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/warfarin-dose-requirement","display_name":"warfarin dose requirement","score":0.9039999842643738},{"id":"https://openalex.org/keywords/cyp2c9-polymorphism","display_name":"CYP2C9 polymorphism","score":0.9129999876022339},{"id":"https://openalex.org/keywords/vkorc1-1639g-a","display_name":"VKORC1 -1639G>A","score":0.8989999890327454},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.8040000200271606},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.7590000033378601},{"id":"https://openalex.org/keywords/south-indians","display_name":"South Indian population","score":0.7689999938011169},{"id":"https://openalex.org/keywords/cyp2c9-2","display_name":"CYP2C9*2","score":0.8090000152587891},{"id":"https://openalex.org/keywords/cyp2c9-3","display_name":"CYP2C9*3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vkorc1","display_name":"VKORC1","score":0.6190000176429749},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.6949999928474426},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.6060000061988831},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.7570000290870667},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.7620000243186951}],"concepts":[{"id":"https://openalex.org/C2776318485","wikidata":"https://www.wikidata.org/wiki/Q18045930","display_name":"VKORC1","level":5,"score":0.9598188400268555},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.8933301568031311},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.806052565574646},{"id":"https://openalex.org/C2776765323","wikidata":"https://www.wikidata.org/wiki/Q82305736","display_name":"Vitamin K epoxide reductase","level":5,"score":0.7411983013153076},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5529873967170715},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.5134295225143433},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4911825358867645},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4774375855922699},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.394161581993103},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.30055350065231323},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0515228807926178},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2185220959","doi":null,"is_oa":false,"landing_page_url":"https://www.ijpp.com/IJPP%20archives/2013_57_3_July%20-%20Sep/308-317.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W1515782956","https://openalex.org/W1558433062","https://openalex.org/W1599071048","https://openalex.org/W1967783552","https://openalex.org/W1968825981","https://openalex.org/W1969839955","https://openalex.org/W1977280638","https://openalex.org/W1979357552","https://openalex.org/W1979862336","https://openalex.org/W1984102038","https://openalex.org/W1992111447","https://openalex.org/W1992910763","https://openalex.org/W1998461499","https://openalex.org/W2003370018","https://openalex.org/W2006566690","https://openalex.org/W2006660249","https://openalex.org/W2011913653","https://openalex.org/W2012050100","https://openalex.org/W2013375415","https://openalex.org/W2017538702","https://openalex.org/W2019399182","https://openalex.org/W2020554169","https://openalex.org/W2029583153","https://openalex.org/W2039500477","https://openalex.org/W2042292509","https://openalex.org/W2043674997","https://openalex.org/W2060258790","https://openalex.org/W2061739968","https://openalex.org/W2073695143","https://openalex.org/W2074183872","https://openalex.org/W2074257646","https://openalex.org/W2074480733","https://openalex.org/W2078517865","https://openalex.org/W2081850567","https://openalex.org/W2088641612","https://openalex.org/W2095670022","https://openalex.org/W2101966493","https://openalex.org/W2102553995","https://openalex.org/W2112940339","https://openalex.org/W2121527202","https://openalex.org/W2123198632","https://openalex.org/W2125650394","https://openalex.org/W2132727148","https://openalex.org/W2144634347","https://openalex.org/W2145049802","https://openalex.org/W2149319043","https://openalex.org/W2151774137","https://openalex.org/W2151936813","https://openalex.org/W2157168176","https://openalex.org/W2164327527","https://openalex.org/W2170483665","https://openalex.org/W2181560086","https://openalex.org/W2184521028","https://openalex.org/W2250144831","https://openalex.org/W2481077525"],"related_works":["https://openalex.org/W2169304562","https://openalex.org/W2001501614","https://openalex.org/W1997493418","https://openalex.org/W4415323095","https://openalex.org/W2373349214","https://openalex.org/W2012050100","https://openalex.org/W2003696901","https://openalex.org/W2414530322","https://openalex.org/W1979357552","https://openalex.org/W2928652646"],"abstract_inverted_index":{"Cytochrome":[0],"P450":[1],"2C9":[2],"(CYP2C9)":[3],"and":[4,26,38,73,75,98,100,107,129,150,155],"vitamin":[5],"K":[6],"epoxide":[7],"reductase":[8],"complex":[9],"subunit":[10],"1":[11],"(VKORC1)":[12],"genetic":[13,40,151],"polymorphisms":[14,41,152],"were":[15,67,78,102],"strongly":[16],"associated":[17],"with":[18,57,80,123,134],"warfarin":[19,43,56,83,117],"dose":[20,44,84,118],"requirement":[21,45],"in":[22,46,121,162,164],"Caucasians,":[23],"African":[24],"Americans":[25],"other":[27],"populations.":[28],"Our":[29,110],"aim":[30],"was":[31,93],"to":[32,95,104,132,159],"evaluate":[33],"the":[34,63,114],"effect":[35],"of":[36,52,71,90,127,148,153],"CYP2C9":[37,128,154],"VKORC1":[39,76,91,130,156],"on":[42,55],"south":[47,165],"Indian":[48,166],"population.":[49,167],"A":[50],"total":[51],"150":[53],"patients":[54,122],"stable":[58],"INR":[59],"(2-":[60],"3.5)":[61],"for":[62],"past":[64],"3":[65],"months":[66],"recruited.":[68],"The":[69,86],"genotypes":[70,126],"CYP2C9*2":[72,99],"*3":[74],"-1639G>A":[77,92],"compared":[79,131],"mean":[81,115],"daily":[82,116],"(MDWD).":[85],"variant":[87,135],"allele":[88],"frequency":[89],"found":[94,103],"be":[96,105],"10.4%":[97],"CYP2C9*3":[101],"4.5%":[106],"6.6%,":[108],"respectively.":[109],"study":[111],"showed":[112],"that":[113,141],"is":[119],"higher":[120],"wild":[124],"type":[125],"those":[133],"genotypes.":[136],"Multivariate":[137],"regression":[138],"analysis":[139],"revealed":[140],"age,":[142],"body":[143],"mass":[144],"index":[145],"(BMI),":[146],"duration":[147],"therapy":[149],"together":[157],"contribute":[158],"36.1%":[160],"variability":[161],"MDWD":[163]},"counts_by_year":[{"year":2018,"cited_by_count":3},{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}